Venlafaxine Market, By Indication (Major Depressive Disorder, Anxiety Disorder, Panic Disorder, Obsessive-Compulsive Disorder, Post-Traumatic Stress Disorder, Other Psychiatric Disorders), By Type (Generic, and Branded), By Dosage Form and Strength (Immediate-Release Tablets (25 mg, 37.5 mg, 50 mg, 75 mg, 100 mg), Extended-Release Capsules (37.5 mg, Extended-Release Tablets, and Oral Solution), By Age Group (Adults (18–64 years), and Geriatric Population (65 years and above)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Psychiatric Clinics, Homecare Settings, Long-Term Care Facilities, Rehabilitation Centers, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)